Pharmacology And Medications Flashcards

1
Q

Name a drug for hormone therapy in breast cancer and explain it s function

A

Tamoxifen - targets breast cancer cells with oestrogen receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name a drug for treating breast cancer which has HER2 receptor

A

Herceptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define hypersensitivity

A

reaction to an allergen which in the same dose is tolerated by normal subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

explain the pathophysiology of type 1 hypersensitivity

A

Prior exposure to the antigen/drug
IgE antibodies formed after exposure to molecule
IgE becomes attached to mast cells or leucocytes, expressed as cell surface receptors
Re-exposure causes mast cell degranulation and release of pharmacologically active substances such as histamine, prostaglandins, leukotrienes, platelet activating factor etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

explain type 2 hypersensitivity reactions

A

Drug or metabolite combines with a protein
Body treats it as foreign protein and forms antibodies (IgG, IgM)
Antibodies combine with the antigen and complement activation damages the healthy cells e.g. rheumatoid arthritis

Type 2 hypersensitivity is like a case of mistaken identity in the body. It happens when the immune system mistakenly targets healthy cells or tissues, thinking they’re harmful. This can lead to various conditions where the body attacks its own cells or cells perceived as foreign, causing harm or damage. Examples include autoimmune disorders like rheumatoid arthritis or certain types of anemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

explain type 3 hypersensitivity

A

Antigen and antibody form large complexes and activate complement
Small blood vessels are damaged or blocked because of accumulation of these complexes. Accumulation of these deposits also triggers inflammation as leucocytes are attracted to site.

Ex.: glomerulonephritis, vasculitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

explain type 4 hypersensitivity

A

Antigen specific receptors develop on T-lymphocytes
Subsequent administration leads to local or tissue allergic reaction and subsequent formation of granulomas.
E.g. contact dermatitis
E.g. Stevens Johnson syndrome (TEN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the symptoms of anaphylaxis

A

must say rash, swelling of lips face oedema, central cyanosis, wheeze, hypotension, cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the ABCDE approach and how do you examine each

A

airway - involves assessing the patient’s airway to ensure it’s open and unobstructed. If there’s a blockage or if the patient is having difficulty breathing, immediate interventions such as clearing the airway or placing an artificial airway

breathing - Evaluate the patient’s breathing pattern, rate, and oxygenation. Ensure adequate ventilation, and address any respiratory distress or signs of inadequate breathing. Interventions might include providing supplemental oxygen, assisting ventilation, or treating underlying causes of respiratory failure.

circulation - Assess the patient’s circulation, including their pulse, blood pressure, and signs of adequate perfusion. Treat any signs of shock or inadequate blood flow, such as administering fluids, medications to support blood pressure, or interventions to improve cardiac function if needed.

disability - evaluating the patient’s neurological status, including their level of consciousness, neurological deficits, or signs of altered mental status.

exposure - checking the patients for wounds and things and also look around to see if the environment is safe for the patient so that you can take action if required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are common triggers of anaphylaxis

A

peanuts
cow’s milk
gluten
antibiotics
chemotherapy drugs
contrast media
NSAIDs
insect venom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe the late response in anaphylaxis

A

happens a couple hours after the initial response –> due to the recruitment of more inflammatory mediators you get a second anaphylactic episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the management of anaphylaxis

A

Commence basic life support. ABC

Stop the drug if infusion
Adrenaline IM –> 500micrograms(300mcg epi-pen)
High flow oxygen
IV fluids – aggressive fluid resuscitation
If anaphylactic shock may need IV adrenaline with close monitoring
Antihistamines not first line treatment but can be used for skin symptoms
Corticosteroids no longer recommended
Lie sitting or flat to breathe more easily
Lift legs to help fluid circulate  prevent oedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how does adrenaline affect all adrenergic receptors

A

alpha 1 receptors
Vasoconstriction - increase in peripheral vascular resistance, increased BP and coronary perfusion
Reduces oedema

Beta1-adrenoceptors
positive ionotropic and chronotropic effects on the heart

Beta 2 adrenoreceptors bronchodilates

alpha 2 adrenoreceptors
Attenuates further release of mediators from mast cells and basophils by increasing intracellular c-AMP and so reducing the release of inflammatory mediators (the negative feedback loop)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what do you do if a patient has refractory anaphylaxis

A

refractory anaphylaxis –> no improvement in symptoms despite 2 doses of IM adrenaline
give IM adrenaline every 5 min until IV adrenaline infusion is started
high flow o2
monitor heart for cardiac arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what blood test is used to confirm anaphylaxis and why

A

mast cell tryptase because it shows rate of mast cell degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

risk factors for hypersensitivity

A

Females > Males
EBV (Epstein barr virus)
HIV
Previous drug reactions
Uncontrolled asthma
Certain HLA groups
liver metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are μ receptors

A

one of the three main types of opioid receptors found in the body. Activation of the μ receptor plays a significant role in mediating the effects of opioid drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

A 60 year old woman presents to her General Practice with tiredness and dry skin. She is found to have hypothyroidism and is started on oral levothyroxine 75mcg tablets, 1 tablet daily.
Levothyroxine tablets have a variable bioavailability between individuals.
Which of the following is most likely to cause a reduction in bioavailability?
A) Short bowel syndrome
B) Reduced renal function
C) Low albumin
D) Hepatic impairment
E) Low body weight

A

A

Bioavailability is the proportion of the substance that enters the bloodstream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A pharmaceutical company is developing a new drug (drug x) for the treatment of heart failure. The half life (t1/2) of drug x is found to be 6-10 hours (average 8 hours).
Which of the following could increase the half life (t1/2) of a drug?
A) Co-administration of a CYP450 enzyme inducer
B) Impaired absorption from GI tract
C) Increasing the administered dose
D) Changing formulation from oral to IV
E) Renal impairment

A

E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which of the following types of drug interactions would result in an increased therapeutic effect and potential drug toxicity?
A) Amiodarone displacing warfarin from plasma albumin
B) Bisoprolol opposing the action of salbutamol at β2 receptors
C) Oral iron forming an insoluble drug complex with doxycycline
D) Phenytoin inducing the CYP450 enzyme which metabolises warfarin
E) Rifampicin inducing Pgp which transports rivaroxaban

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drug y is an antagonist at B1 receptors. Which of the following adverse drug reactions is a B1 antagonist most likely to cause?
A) Tremor
B) Bradycardia
C) Urinary retention
D) Hypertension
E) Dry mouth

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which type of adverse drug reaction is most likely to be identified during clinical trials?
A) Bizzare
B) Delayed
C) Chronic
D) Augmented
E) Genetic

A

D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Match the following pharmacodynamic mechanisms with the most likely adverse drug reaction:

Bradycardia
Tremor
Pupil constriction.
Constipation 𝜇 agonism
Urinary retention

M3 antagonism
M3 agonism
𝛽2 agonism
𝛽1 antagonism
𝜇 agonism

A

Bradycardia 𝛽1 antagonism

Pupil constriction M3 agonism

Urinary retention M3 antagonism

Tremor 𝛽2 agonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what is the difference between first order and second order kinetics

A

first order –> constant % drug is eliminated over time –> trend is exponential for drug plasma conc/time
second order –> constant amount of drug is eliminated over time –> trend is inverse proportional for drug plasma conc over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

what is a modified release drug

A

medication designed to release active ingredients in a controlled or extended manner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what are the different types of modified release drugs

A

extended-release - slow release over time

delayed-release - release drugs at a specific location in the GI

pulsatile-release - release of drug at specific intervals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what effect does modified release doing have on the maximum plasma concentration

A

it decreases it because it slows down the absorption of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

how is the half-life of an IV drug affected if you give it at half the dose

A

it is not affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what does the half-life of a drug depend on

A

clearance and Vd of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

how long does is take to clear 97% of a drug from the body in half lives in a first order kinetics drug

A

5 half lives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

what kind of drugs are more likely to give withdrawal symptoms; short or long half life

A

short half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what is the steady state in drug administration

A

the point at which the rate of drug input = the rate of drug elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

you are administering a drug of first order kinetics
if you give a continuous IV infusion how long does it take in half lives till you reach steady state

A

5 x half life –> because you need to start eliminating the drug to reach a steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

what effect does a 50% dose reduction in an iv infusion have on drug plasma concentration at steady state and the time required to reach steady state

A

drug plasma concentration –> reduction to half
time required to reach ss –> unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

what effect does reduced clearance have on half life, time needed to reach steady state, and plasma concentration at steady state.

A

they will all increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is a loading dose

A

providing an initial larger dose of a drug to ensure a quick therapeutic response –> used in emergencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

A 66 year old woman is admitted to A&E with SOB and haemoptysis.
CTPA confirms bilateral PEs. She is prescribed an IV loading dose of unfractionated heparin 5000 units followed by an IV continuous infusion. What effect will the loading does have on the heparin pharmacokinetics?
a) reduce half life
b) increase bioavailability
c) reduce time to steady state plasma conc
d) increase Vd
e) reduce drug clearance

A

c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

what is druggability

A

a target in our bodies that is known to have high affinity for binding drugs and which upon binding with the drug acts with a therapeutic benefit to patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

what are potential drug targets

A

receptors
enzymes
transporters
ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what are statins

A

cholesterol lowering drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

what are the 4 types of receptors

A

ligand-gated ion channels
G protein coupled receptors
Kinase-linked receptors
Nuclear receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what is potency

A

the amount of drug that you need to cause a maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

what are all of the types of histamine receptors and their roles

A

H1 - allergic reactions
H2 - gastric acid secretion
H3 - associated with CNS disorders
H4 - immune system and inflammatory conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

what is EC50

A

the concentration that gives half the maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

what are receptor affinity and efficacy

A

affinity - how well a ligand binds to a receptor
efficacy - how well a ligand activates a receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

how i potency measured

A

via EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

what is inverse agonism

A

when a drug bonds to the same receptor as an agonist but produces the opposite response to the agonsit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

what happens to receptors as tolerance is achieved

A

the receptors are downregulated so you would need higher doses of the drug to achieve the same response

44
Q

what is efficacy in pharmacology

A

the maximum achievable response form a drug-receptor interaction

44
Q

how fast does opioid withdrawal start

A

within 24 hours

44
Q

what is a receptor reserve

A

spare receptors –> some drugs don’t need to interact with all receptors to achieve a maximal response in the system

45
Q

what is an antagonist of nicotinic receptors and what effect would you think that it would have on the patient

A

curare
a neuromuscular blocking agent that blocks the action of acetylcholine at the neuromuscular junction, leading to muscle paralysis

45
Q

what is an antagonist of muscarinic receptors and what effect would it have on a patient

A

atropine

stops parasympathetic activity (patient will get increased HR, dialeted pupils, increased BP, decreased saliva secretion)

46
Q

what are the clinical uses of glucocorticoids

A

SKIN COND
skin eczema and psoriasis

BREATHING COND TO DILATE BRONCHI
asthma, allergies, COPD

INFLAMMATION SURPRESSION
inflammatory bowel disease
inflammatory arthritis (rheumatoid arthritis)
meningitis

AUTOIOMMUNE STUFF
MS

GLUCOCORTICOID DEFICIENCY
adrenal failure

47
Q

how do glucocorticoids affect BP

A

Glucocorticoids influence blood pressure by regulating the sensitivity of blood vessels to other hormones like adrenaline and by affecting the reabsorption of water and salts in the kidneys; increases salt reabsorption and hence increases water reabsorption too

48
Q

what do statins inhibit and why

A

HMG-CoA reductase because it is the enzyme of the rate-limiting step in the cholesterol pathway

49
Q

what categories of medications can you prescribe to decrease BP

A

ACE inhibitors
Angiotensin 2 receptor blockers
Alpha-blockers
Beta-blockers
Calcium channel blockers
Diuretics

(Think AAABCD)

50
Q

what is amlodipine, how does it work, and what are its effects

A

amlodipine = angioselective calcium channel blocker

it stops the movement of calcium ions in smooth muscle cells and cardiac muscle cell

effects: decreases HR, dilates blood vessels, reduces SVR, decreases BP

51
Q

what class of enzyme inhibitors are omeprazole and asprin

A

irreversible enzyme inhibitors

52
Q

what % of oral morphine is metabolised by first pass metabolism

A

50%

53
Q

what are possible routes of administration of opioids

A

transdermal, IV, oral, epidural, IM

54
Q

what type of receptors do opioids work on how do they work

A

G-coupled receptors
they inhibit pain signals at the spinal cord and midbrain

55
Q

what are side effects of opioids

A

respiratory depression, sedation, nausea, vomiting, constipation, itching, immune suppression, and endocrine effects.

56
Q

what is the medical term for prolonged correction

A

priapism

57
Q

which are the cholinergic receptors

A

muscarinic and nicotinic

58
Q

what are the 3 determinants of BP

A

HR, SVR, SV

59
Q

what are vasopressors and what receptor do they act on

A

drugs which cause vasoconstriction; they act on alpha 1 receptors

60
Q

what are the medications which you need to prescribe to obese people?

A

1) anti-coagulants
- aspirin (anti-platelet)
- warfarin (anti-coagulant)
2) cholesterol inhibitors
- statins
3) anti-hypertensives
- ACE inhibitors
4) heart rate regulators
- beta-blockers

61
Q

what are the actions of alpha 2 agonists

A

they reduce the effect of the sympathetic system –> they reduce BP and HR and they can act as sedatives and analgesics

62
Q

give an example of a alpha 2 agonist

A

clonidine

63
Q

how often can you repeat adrenaline and what is the dose for an anaphylaxis IM injection

A

every 3-5 minutes
0.5mg IM

64
Q

what is the dose of IV adrenaline for a cardiac arrest

A

1mg IV

65
Q

name two specific a1 agonists

A

phenylephrine
metaraminol

66
Q

name two a2 agonists

A

clonidine
dexmedetomidine

67
Q

name a beta 1 agonist

A

dobutamine

68
Q

name a beta 2 agonist

A

salbutamol

69
Q

name a general agonist of adrenergic receptors

A

adrenaline

70
Q

what are the subgroups of nicotinic receptors?

A

ganglionic, neuromuscular, and CNS

71
Q

what are signs of acetylcholinesterase inhibitor toxicity

A

midriasis - dialated pupils
tachycardia
weakness
hypertension
fasciculations

72
Q

what are the different types of muscarinic receptors

A

M1 - increases motility and secretions in gut –> helps facilitate CNS effects
M2 - Cardiac
M3 - Exocrine glands and smooth muscle
M4 - CNS
M5 - CNS

73
Q

name an antagonist of nicotinic receptors

A

trimethaphan

74
Q

name 4 antagonists for muscarinic receptors

A

atropine
glycopyrrolate
hyoscine
ipratropium

75
Q

name agonists of nicotinic receptors

A

nicotine and Ach

76
Q

define pharmacodynamics

A

effect of a drug on the body

77
Q

define pharmacokinetics

A

the FATE of the drug in the body

78
Q

what are the 4 main steps of pharmacokinetics?

A

absorption, distribution, metabolism, excretion

79
Q

what is an IT route of administration

A

intrathecal - administered into the spinal theca

80
Q

what is the difference between topical and transdermal penetration

A

the medication is applied on the surface of the skin or mucous surfaces but in topical it stays on skin (eg.: sunscreen), and in trnasdermal it penetrates through skin

81
Q

what factors affects drug absorption

A

lipid solubility
drug ionisation —> ionisation decreases solubility
route of administration —> if drug has to pass first-pass metabolism it needs to resist the strong pH of the stomach to get absorbed in the intestines

82
Q

what are the factors affecting oral drug absorption

A

gastric enzymes
low pH
food —> will slow down gastric emotying and hence decrease absorption
gastric motility
previous surgery
drug properties (lipid soluble/ionised/hydrophillic)
if the drug has a capsule for modified release
interaction with P-gp!!! —> moves drugs back out of the GI

83
Q

what is bioavailability

A

the proportion of administered drug that actually reaches the systemic circulation

84
Q

what affects drug distribution

A

molecule size
lipid solubility
protein binding

85
Q

what does “Vd” stand for

A

Volume of distribution —> volume of plasma required to contain the administered dose

86
Q

why is it hard for drugs to reach the CNS

A

BBB

87
Q

in what ways can drugs reach the CNS

A

High lipid solubility
Intrathecal administration
Inflammation

88
Q

what enzyme does the phase 1 metabolism of drugs depend on

A

CYP450

88
Q

what are phase 1 and phase 2 reactions

A

phase 1 - oxidation, reduction, hydrolysis (reactions catalysed by CYP450)
phase 2 - conjugation of a functional group to produce a hydrophilic molecule so that it can be excreted in urine (ex.: glucuronidation, sulfation, methylation)

88
Q

what are synergistic pharmacodynamic interactions

A

when 2 substances combine to produce an effect greater than the sum of their individual effects

88
Q

what affects renal excretion of drugs

A

GFR
Active tubular secretion —> where the peritubular capillaries actively secrete the toxins and drugs in the nephron tube
Passive reabsorption

88
Q

what is an induction drug and give an example

A

a drug given to put a patient to sleep
ex.: propofol and thiopentone

88
Q

which is the most effective form or renal clearance and how is it carried out

A

Active tubular secretion and via OAT or OCT

89
Q

give an example of an important drug-food interaction and explain why

A

warfarin or statin taken with GRAPEIT juice
grapefruit juice is a CYP3A4 inhibitor which is supposed to metabolise those meds.

milk can affect the absorption of some drugs (doxycycline antibiotic) due to the formation of insoluble complexes with Ca

warfarin can’t be taken with foods high in vit K as warfarin is a vitamin K antagonist

warfarin also can’t be taken with cranberry juice as cranberry juice is a CYP2CP inhibitor

89
Q

how can drug interactions be predicted and avoided

A

Understand the Pharmacokinetics and Pharmacodynamics of prescribed drugs.

Use Reliable Resources

Perform Thorough Medication Reviews including prescription medications, over-the-counter drugs, herbal supplements, and vitamins.

Consider Patient-Specific Factors: Individual factors such as age, gender, genetics, underlying health conditions, organ function, and other medications being taken

Educate patients about the importance of disclosing all medications to healthcare providers.

Consider Alternative Therapies: When possible, consider alternative medications or therapies that have a lower risk of interactions. Choose drugs with different mechanisms of action or routes of metabolism to minimize the likelihood of interactions.

Be Mindful of Food and Drug Interactions: Some medications interact with certain foods or beverages, affecting their absorption or metabolism. Educate patients about these interactions and advise them on appropriate dietary modifications if necessary.

Monitoring of drug action (bloods, observations)

89
Q

what patients are at high risk of drug interactions

A

patients who take many meds –> polypharmacy
patients with kidney and liver disease
extremes of age

89
Q

what are the types of adverse drug reactions and what do they mean

A

A - Augmented
(predictable and related to the known pharmacological properties of the drug; NOT LIFE THREATENING)

B - Bizarre
(not related to the intended action of the drug; SEVERE ex.: anaphylaxis)

C - Chronic
(due to long-term use and cumulative dose effects ex: kidney damage due to long term use of metformin)

D - Delayed
(reactions that appear a long time after starting the use of the meds and are chronic but do not necessarily require prolonged and continued use. ex.: chemotherapy-induced cancer - leucopenia)

E - End of use
(withdrawal symptoms)

F - Failure of treatment

G - Genetic
(drug causes damage to the genome)

89
Q

what does the DoTS way for classifying ADRs (alternative drug reactions) stand for

A

dose-relatedness
timing
susceptibility

89
Q

what is the yellow card

A

the system used to report any alternative and serious drug reactions and possible unlicensed uses of a drug

89
Q

what are black triangle medicines

A

medicines which are subject to post-market surveillance ; all of their adverse drug reactions have to be reported

90
Q

what gene encodes for MHC

A

HLA

91
Q

what is Stevens-Jhonson syndrome

A

overreaction of immune system to a trigger which leads to bleeding and peeling of skin and surfaces of the eyes, mouth, and throat

92
Q

what are factors thought to increase the incidence of anaphylaxis?

A

pollution
age
gender
changes in pollen patterns
Vit D deficiency
increase in C-section
chemicals

93
Q

what are the histamine receptors and why are the important in anaphylaxis treatment

A

H1 Receptors –> found on smooth muscle cells, endothelial cells, and certain neurons. their stimulation causes VASODILATION and BRONCHOCONSTRICTION

they are part of the allergic response

they are important because antihistamine medications target H1 receptors to alleviate anaphylaxis symptoms like itching, sneezing and runny nose.

H2 Receptors –> mainly located on the surface of parietal cells in the stomach lining.
Activation of H2 receptors stimulates the secretion of gastric acid into the stomach.

H1 receptor antagonists, such as diphenhydramine and cetirizine, are commonly used to treat allergic reactions and symptoms.
H2 receptor antagonists, including ranitidine and famotidine, are used to reduce stomach acid production in conditions associated with excess gastric acid secretion.

There are also H3 and H4 –> function not well known

HISTAMINE 1 EXPLANATION:
Histamine, when binding to H1 receptors, can produce a variety of physiological effects, and the symptoms of sneezing and itching are attributed to specific actions in different tissues:

Sneezing:

Histamine, acting on H1 receptors in the nasal mucosa, stimulates the sensory nerves and triggers the reflex that leads to sneezing. This response is part of the body’s defense mechanism to remove irritants from the nasal passages.
Itching:

Histamine-induced itching is often related to the release of other substances, such as prostaglandins and leukotrienes, in response to histamine binding to H1 receptors on sensory nerves. These mediators contribute to the sensation of itching.
While histamine, through H1 receptors, can cause vasodilation and bronchoconstriction, the action of H1 receptor blockers (antihistamines) is more complex. Antihistamines selectively block the effects of histamine on H1 receptors, which is why they are effective in alleviating symptoms like sneezing and itching. However, they may not completely counteract all actions of histamine or may have different effects in various tissues.

Regarding vasodilation and bronchoconstriction:

Vasodilation: H1 receptor blockers can counteract histamine-induced vasodilation to some extent, particularly in peripheral blood vessels. This is why first-generation antihistamines, which can cause sedation and have some anti-cholinergic effects, may also lead to mild decreases in blood pressure due to their vasodilatory actions.

Bronchoconstriction: Antihistamines, especially first-generation ones, may not fully counteract histamine-induced bronchoconstriction. In fact, some first-generation antihistamines may cause mild bronchoconstriction in susceptible individuals. For bronchodilation, medications targeting beta-2 adrenergic receptors (beta-2 agonists) are more commonly used.

94
Q

what are the medications that end in “pril”

A

ACE inhibitors

95
Q

what are the medications that end in “sartan”

A

ARBs
Angiotensin 2 receptor blockers

96
Q

what are the medications that end in “dipine”

A

Ca channel blockers

97
Q

what are the medications that end in “olol”

A

Beta blockers

98
Q

what are the medications that end in “ide”

A

loop diuretics

99
Q

what are the medications that end in “thiazide”

A

thiazide diuretics